Background A number of recent case reports and series have identified a subgroup of
atypical fractures of the femoral shaft associated with bisphosphonate use. A population …

Background Studies show conflicting results regarding the possible excess risk of atypical
fractures of the femoral shaft associated with bisphosphonate use. Methods In Sweden …

Bisphosphonates reduce the rate of osteoporotic fractures in clinical trials and community
practice.“Atypical” nontraumatic fractures of the diaphyseal (subtrochanteric or shaft) part of …

Background and purpose—Use of bisphosphonates in women is associated with higher risk
of atypical femoral fractures. The risk in terms of timing of use and type of bisphosphonate …

Atypical fractures of the femur below the lesser trochanter have been reported in patients
treated with bisphosphonates. We performed a systematic literature search of case/case …

Although there is strong evidence that bisphosphonates prevent certain types of
osteoporotic fractures, there are concerns that these medications may be associated with …

Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid‐induced
osteoporosis. Case series suggest a potential link between prolonged use of …

BACKGROUND: Reports of atypical femur fracture in bisphosphonate-exposed women have
prompted interest in characterizing the clinical profiles of these patients. METHODS: Among …

Recent evidence has linked long-term bisphosphonate use with insufficiency fractures of the
femur in postmenopausal women. In this case–control study, we have identified a significant …

Background Bisphosphonates are effective in reducing hip and osteoporotic fractures.
However, concerns about atypical femur fractures have contributed to substantially …